Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)
ID: 358080Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing HIV/AIDS Research within the Mission of the NIDCD," aimed at stimulating research related to HIV/AIDS and communication disorders. This initiative encourages applications that address high-priority research areas defined by the NIH Office of AIDS Research, focusing on the impact of HIV on hearing, balance, taste, smell, voice, speech, and language, with a budget limit of $275,000 for a two-year project period. Eligible applicants include a diverse range of institutions and organizations, and only low-risk clinical trials that do not require FDA oversight will be supported. Interested parties can find more information and application details at the NIH grants website, with deadlines for submissions ranging from May 2025 to January 2028.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Health and Human Services, through the National Institutes of Health (NIH), announces a funding opportunity titled "Advancing HIV/AIDS Research within the Mission of the NIDCD." This initiative, categorized under the R21 Exploratory/Developmental Research Grant, aims to stimulate HIV/AIDS research relevant to communication disorders, specifically in hearing, balance, taste, smell, voice, speech, and language. Eligible applicants include various higher education institutions and organizations, with a budget limit of $275,000 for a two-year project period. The funding seeks applications that address high-priority HIV/AIDS research areas defined by the NIH Office of AIDS Research, such as the impact of HIV on communication disorders and the development of treatment strategies. Only low-risk clinical trials that do not require FDA oversight are supported. Application deadlines range from May 2025 to January 2028, with funding contingent upon NIH appropriations and the quality of submitted proposals. Compliance with detailed application instructions and adherence to NIH policies is critical for successful project proposals, emphasizing the scientific merit, innovation, and feasibility of the research.
    Similar Opportunities
    Loading similar opportunities...